Nov 7 (Reuters) - Aytu Bioscience Inc AYTU.O :
* Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys system for male infertility
* Aytu Bioscience Inc - expects to announce a distribution partner and launch Mioxsys for clinical use in coming quarters
* Aytu Bioscience Inc - has engaged in australian market development activities and is in early discussions with distribution partners
* Aytu Bioscience - Mioxsys been approved by TGA as an aid in diagnostic assessment of semen quality for patients undergoing male infertility evaluation